HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of steroids in idiopathic facial nerve paralysis: an open, randomized, prospective controlled study.

AbstractOBJECTIVES:
Although corticosteroid therapy is widely used in idiopathic facial nerve paralysis, its efficacy has not been clearly demonstrated. This study was designed to evaluate the role of steroids in idiopathic facial nerve paralysis.
PATIENTS AND METHODS:
The study included 56 patients (29 males, 27 females; mean age, in men 44.1, in women 40.3 years) with a diagnosis of idiopathic facial nerve paralysis. Within the first three days after the onset of symptoms, the patients were randomly assigned to two groups to receive either steroids or other medications for the prevention of ocular complications or to provide pain relief. The severity of facial paralysis was evaluated using the House-Brackmann classification before and after three and six weeks of the treatment. Regression to stage 1 or 2 disease was regarded as a successful response.
RESULTS:
Although the initial response to steroid therapy seemed to be better, the results at the end of three and six weeks of the treatment were not statistically different from those of patients receiving other supportive treatments (p>0.05).
CONCLUSION:
Further studies with large patient series are needed to clarify the use of steroids in the treatment of idiopathic facial nerve paralysis.
AuthorsUlkü Türk-Börü, Abdulkadir Koçer, Cevdet Bilge
JournalKulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat (Kulak Burun Bogaz Ihtis Derg) Vol. 14 Issue 3-4 Pg. 62-6 ( 2005) ISSN: 1300-7475 [Print] Turkey
PMID16227727 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Glucocorticoids
  • Methylprednisolone
Topics
  • Administration, Oral
  • Adult
  • Bell Palsy (drug therapy, pathology)
  • Drug Administration Schedule
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Male
  • Methylprednisolone (administration & dosage)
  • Prospective Studies
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: